• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎的质量指标:来自 METEOR 数据库的结果。

Quality indicators in rheumatoid arthritis: results from the METEOR database.

机构信息

Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands,

Department of Internal Medicine III, Medical University of Vienna 2nd Department of Medicine, Center for Rheumatic Diseases, Hietzing Hospital, Vienna, Austria.

出版信息

Rheumatology (Oxford). 2015 Sep;54(9):1630-9. doi: 10.1093/rheumatology/kev108. Epub 2015 Apr 14.

DOI:10.1093/rheumatology/kev108
PMID:25877910
Abstract

OBJECTIVE

To test the feasibility of collecting, storing, retrieving and analysing necessary information to fulfil a preliminary set of quality indicators (QIs) that have been proposed by an international task force in a large multinational clinical practice database of patients with RA.

METHODS

Data from all 12 487 patients with 46 005 visits in the Measurement of Efficacy of Treatment in the Era of Outcome in Rheumatology database from January 2008 until January 2012 were analysed to test the feasibility of collecting information on 10 QIs: time to diagnosis; frequency of visits; assessment of autoantibodies and radiographs, disease activity and function; disease remission, low disease activity, normal function; time to first DMARD and type of first DMARD. For each QI, two aspects were assessed: information availability and target achievement.

RESULTS

Information was available for <50% of patients regarding the following QIs: time to diagnosis, assessment of ACPAs or radiographs, time to first DMARD and type of first DMARD. Information was available for function assessment in 49% of visits and 67% of patients and for disease activity assessment in 85% of visits and 86% of patients. Information relevant to the QI frequency of visits was available for all patients. Relevant information to calculate the proportion of patients who achieved a defined target could be obtained for all QIs.

CONCLUSION

Collecting storing, retrieving and analysing the core data necessary to meaningfully assess quality of care is feasible in a multinational, practice-based electronic database.

摘要

目的

测试在大型跨国临床实践数据库中收集、存储、检索和分析必要信息以满足国际工作组提出的初步质量指标(QIs)的可行性,这些信息适用于类风湿关节炎患者。

方法

对 2008 年 1 月至 2012 年 1 月期间,来自 Rheumatology 数据库中治疗效果评估时代的疗效测量数据库中的 12487 例患者的 46005 次就诊数据进行分析,以测试收集以下 10 个 QIs 信息的可行性:诊断时间;就诊频率;自身抗体和影像学评估、疾病活动度和功能;疾病缓解、低疾病活动度、正常功能;首次 DMARD 时间和首次 DMARD 的类型。对于每个 QI,评估了两个方面:信息可用性和目标达成情况。

结果

以下 QIs 的患者信息可用性<50%:诊断时间、ACPA 或影像学评估、首次 DMARD 时间和首次 DMARD 的类型。49%的就诊和 67%的患者可获得功能评估信息,85%的就诊和 86%的患者可获得疾病活动度评估信息。所有患者的就诊频率相关信息均可获得。所有 QIs 都可以获得计算达到定义目标的患者比例的相关信息。

结论

在跨国、基于实践的电子数据库中,收集、存储、检索和分析评估护理质量所需的核心数据是可行的。

相似文献

1
Quality indicators in rheumatoid arthritis: results from the METEOR database.类风湿关节炎的质量指标:来自 METEOR 数据库的结果。
Rheumatology (Oxford). 2015 Sep;54(9):1630-9. doi: 10.1093/rheumatology/kev108. Epub 2015 Apr 14.
2
Care quality for rheumatoid arthritis patients in Quebec.魁北克类风湿关节炎患者的护理质量。
Int J Rheum Dis. 2019 Jul;22(7):1233-1238. doi: 10.1111/1756-185X.13580. Epub 2019 Apr 16.
3
American College of Rheumatology quality indicators for rheumatoid arthritis: benchmarking, variability, and opportunities to improve quality of care using the electronic health record.美国风湿病学会类风湿关节炎质量指标:使用电子健康记录进行基准测试、变异性分析及改善医疗质量的机会
Arthritis Rheum. 2008 Dec 15;59(12):1705-12. doi: 10.1002/art.24054.
4
Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts.类风湿关节炎中持续停用改善病情抗风湿药缓解的患病率及预测因素:来自两个大型早期关节炎队列的结果
Arthritis Rheum. 2009 Aug;60(8):2262-71. doi: 10.1002/art.24661.
5
Factors associated with the initiation of disease-modifying antirheumatic drugs in newly diagnosed rheumatoid arthritis: a retrospective claims database study.与新诊断类风湿关节炎开始使用疾病修正抗风湿药物相关的因素:一项回顾性理赔数据库研究。
Clin Ther. 2012 Feb;34(2):457-67. doi: 10.1016/j.clinthera.2011.12.016. Epub 2012 Jan 28.
6
Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial.阿达木单抗联合甲氨蝶呤和关节内曲安奈德治疗早期类风湿关节炎的靶向治疗策略可提高缓解率、功能和生活质量。OPERA 研究:一项由研究者发起的、随机、双盲、平行分组、安慰剂对照试验。
Ann Rheum Dis. 2014 Apr;73(4):654-61. doi: 10.1136/annrheumdis-2012-202735. Epub 2013 Feb 23.
7
Assessment of American College of Rheumatology-Endorsed Quality Indicators in Rheumatoid Arthritis Patients: A Quality Improvement Initiative.类风湿关节炎患者中美国风湿病学会认可的质量指标评估:一项质量改进计划。
J Clin Rheumatol. 2016 Mar;22(2):63-7. doi: 10.1097/RHU.0000000000000323.
8
Outcome of patients with rheumatoid arthritis: cross-sectional study of a single-center real-world inception cohort.类风湿关节炎患者的结局:单中心真实世界起始队列的横断面研究
Isr Med Assoc J. 2013 Dec;15(12):758-62.
9
Quality Indicators for Evaluating the Health Care of Patients with Rheumatoid Arthritis: a Korean Expert Consensus.评价类风湿关节炎患者医疗质量的指标:韩国专家共识。
J Korean Med Sci. 2021 May 3;36(17):e109. doi: 10.3346/jkms.2021.36.e109.
10
Therapeutic strategies in rheumatoid arthritis over a 40-year period.40年来类风湿关节炎的治疗策略
J Rheumatol. 2004 Dec;31(12):2366-73.

引用本文的文献

1
Identification of Five Quality Needs for Rheumatology (Text Analysis and Literature Review).确定风湿病学的五个质量需求(文本分析与文献综述)
Front Med (Lausanne). 2021 Oct 25;8:757102. doi: 10.3389/fmed.2021.757102. eCollection 2021.
2
[Development of quality standards for patients with axial spondyloarthritis for use in Germany].[德国轴向型脊柱关节炎患者质量标准的制定]
Z Rheumatol. 2022 Nov;81(9):730-743. doi: 10.1007/s00393-021-01019-x. Epub 2021 Aug 11.
3
Impact of assessing patient-reported outcomes with mobile apps on patient-provider interaction.
移动应用程序评估患者报告结局对医患互动的影响。
RMD Open. 2021 Apr;7(1). doi: 10.1136/rmdopen-2021-001566.
4
Clinical Outcomes of Patients with Rheumatoid Arthritis Treated in a Disease Management Program: Real-World Results.类风湿关节炎患者在疾病管理项目中的临床结局:真实世界结果
Open Access Rheumatol. 2020 Nov 6;12:249-256. doi: 10.2147/OARRR.S270700. eCollection 2020.
5
The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus.韩国生物性疾病修饰抗风湿药物治疗炎症性关节炎的应用:韩国专家共识结果。
Korean J Intern Med. 2020 Jan;35(1):41-59. doi: 10.3904/kjim.2019.411. Epub 2020 Jan 2.
6
Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis.制定 ASAS 质量标准,以提高患有中轴型脊柱关节炎患者的健康和医疗服务质量。
Ann Rheum Dis. 2020 Feb;79(2):193-201. doi: 10.1136/annrheumdis-2019-216034. Epub 2019 Oct 11.
7
Remission rate and predictors of remission in patients with rheumatoid arthritis under treat-to-target strategy in real-world studies: a systematic review and meta-analysis.真实世界研究中靶向治疗策略下类风湿关节炎患者的缓解率及缓解预测因素:系统评价和荟萃分析。
Clin Rheumatol. 2019 Mar;38(3):727-738. doi: 10.1007/s10067-018-4340-7. Epub 2018 Oct 19.
8
A 4-year non-randomized comparative phase-IV study of early rheumatoid arthritis: integrative anthroposophic medicine for patients with preference against DMARDs versus conventional therapy including DMARDs for patients without preference.早期类风湿性关节炎的4年非随机对照IV期研究:为偏好非改善病情抗风湿药(DMARDs)的患者提供整合人智医学,为无偏好的患者提供包括DMARDs在内的传统疗法。
Patient Prefer Adherence. 2018 Mar 16;12:375-397. doi: 10.2147/PPA.S145221. eCollection 2018.
9
Leveraging the electronic health record to improve quality and safety in rheumatology.利用电子健康记录改善风湿病学的质量和安全性。
Rheumatol Int. 2017 Oct;37(10):1603-1610. doi: 10.1007/s00296-017-3804-4. Epub 2017 Aug 29.
10
Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study.类风湿关节炎中,巴瑞替尼与安慰剂或阿达木单抗对比的3期研究的患者报告结局:RA-BEAM研究的二次分析
Ann Rheum Dis. 2017 Nov;76(11):1853-1861. doi: 10.1136/annrheumdis-2017-211259. Epub 2017 Aug 10.